Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-08 |
filingDate |
2014-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-6057947-B2 |
titleOfInvention |
Compositions and methods for reducing side effects and toxicity by administering methotrexate as an orotic acid derivative |
priorityDate |
2007-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |